SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GTC Biotherapeutics
An SI Board Since December 2005
Posts SubjectMarks Bans Symbol
135 7 0 GTCB
Emcee:  SI (no user) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
110dew, there is a tremendous amount of neg comments about gtcb on all the boardsosofun-5/22/2008
109Edited transcript of GTCB 1Q08 CC: siliconinvestor.com Updated GTCB ‘ReadMeFirsDewDiligence_on_SI-5/8/2008
108GTCB used to be my largest biotech position; it’s now my second-largest after MNDewDiligence_on_SI-4/12/2008
107Dew, everywhere I look, I see you posting. You must own a ton of GTCB.bits-4/12/2008
106GTCB ‘ReadMeFirst’ updated re insider shareholdings, PharmAthene, Kamada, a possDewDiligence_on_SI-4/6/2008
105Please use this link instead: siliconinvestor.comDewDiligence_on_SI-3/7/2008
104Edited Transcript from 4Q07 CC: siliconinvestor.comDewDiligence_on_SI-3/7/2008
103GTCB ‘ReadMeFirst’ updated for today’s financing deal: siliconinvestor.comDewDiligence_on_SI-2/8/2008
102GTCB 'ReadMeFirst' updated for results of phase-3 ATryn trial and miscelDewDiligence_on_SI-2/5/2008
101GTC Reports Positive Top-Line Results of Phase-3 ATryn Trial in Hereditary DefiDewDiligence_on_SI-2/4/2008
100GTCB <i>ReadMeFirst</i> updated re AT and FVIIa reference lists and DewDiligence_on_SI-1/20/2008
99GTCB ‘ReadMeFirst’ updated: <i>[Updates on various subjects: musings on DewDiligence_on_SI-1/13/2008
98GTCB <i>ReadMeFirst</i> updated re news flow, insider holdings, and DewDiligence_on_SI-1/2/2008
97GTC’s Role in Follow-On Biologics: siliconinvestor.comDewDiligence_on_SI-12/12/2007
96FDA grants Orphan Drug status for ATryn in HD: siliconinvestor.com siliconinvesDewDiligence_on_SI-12/10/2007
95Edited transcript from 3Q07 CC: siliconinvestor.comDewDiligence_on_SI-11/2/2007
94From the Transgenics board: #msg-23899385.DewDiligence_on_SI-9/20/2007
93Edited Transcript from 2Q07 Conference Call: tinyurl.com By reading this one pDewDiligence_on_SI-8/13/2007
92As there appears to be little interest in GTCB on SI, there is little incentive DewDiligence_on_SI-5/11/2007
91GTCB ‘ReadMeFirst’ updated: investorshub.comDewDiligence_on_SI-5/4/2007
90<u> What is GTC’s Business Model? </u> The simplified version: <DewDiligence_on_SI-5/4/2007
89Edited transcript from GTCB 1Q07 CC: investorshub.comDewDiligence_on_SI-5/4/2007
88GTCB <i>ReadMeFirst</i> updated: investorshub.comDewDiligence_on_SI-4/30/2007
87<b>GTCB <i>ReadMeFirst</i> updated </b> Expanded discusDewDiligence_on_SI-4/8/2007
86Venn Diagram of GTCB’s Business Model: investorshub.comDewDiligence_on_SI-3/16/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News